Quant Large and Mid Cap Fund
Direct · GrowthAI Summary
Quant Large and Mid Cap Fund has delivered strong SIP XIRR of 19.82% over 3 years and 20.4% over 5 years, consistently beating category averages of 18.19% and 18.04% respectively. Against the NIFTY 50, the fund shows positive alphas across all periods, including 8.55% over 3Y and 9.44% over 5Y, with longer-horizon Fund CAGRs of 15.11% (10Y) versus the benchmark's 10.33%. Recent performance has moderated, with 5.63% in 2026 year-to-date and a negative 1.36% in 2025.
The fund shows favorable asymmetry, with downside capture of 76.97-83.59% over longer horizons versus upside capture near or above 90-104%, and 1Y downside capture of just 80.23%. However, drawdown behavior warrants attention: the maximum drawdown of -0.4570 required 1723 days to recover after a 278-day drawdown duration, and there have been 6 drawdown events exceeding 10% over the period. Calmar ratios in the 0.40-0.48 range across durations indicate moderate risk-adjusted efficiency relative to peak-to-trough losses.
The portfolio holds 23 stocks with the top 10 accounting for roughly two-thirds of NAV, led by Aurobindo Pharma (9.76%) and Lloyds Metals and Energy (9.74%). A notable Adani group concentration exists, with Adani Enterprises, Adani Green Energy, and Adani Power jointly at 18.38% of NAV. Sector exposure is concentrated in Pharmaceuticals (17.4%), Power (13.3%), and Auto Components (11.3%), leaving the portfolio vulnerable to idiosyncratic group-level and sector-specific shocks.
The fund outperforms category average SIP XIRR across every reported horizon, from 15.62% vs 11.01% at 1Y to 19.37% vs 16.82% at 10Y, indicating durable outperformance. Long-term consistency is supported by strong calendar year returns such as 65.08% in 2014, 37.73% in 2021, and 33.26% in 2023. However, negative years like 2025 (-1.36%) and 2018 (-7.52%) show it can underperform in weak markets despite better-than-benchmark downside capture.
This fund suits investors with high risk tolerance seeking large and mid cap exposure with an active, conviction-heavy style, given its concentrated 23-stock portfolio and 18.38% Adani group exposure. A horizon of at least 5-7 years is advisable, as the recovery from maximum drawdown took 1723 days and strong results emerge over longer holding periods. SIP investors comfortable with interim volatility but seeking above-category-average XIRR will find it a reasonable fit.
- SIP XIRR beats category average at every horizon, including 19.82% vs 18.19% over 3Y and 20.4% vs 18.04% over 5Y
- Strong downside protection with downside capture of 76.97%-83.59% over 7Y-15Y, combined with positive alpha of 5.32%-9.63% across long horizons
- Low-cost access at a 0.61% expense ratio with a long-term track record of 12+ years of above-benchmark CAGR
- High group-level concentration from three Adani holdings totaling 18.38% of NAV, plus a concentrated 23-stock portfolio
- Prolonged recovery from maximum drawdown (1723 days) and recent weak calendar years, including -1.36% in 2025 and 5.63% in 2026, suggest near-term momentum has slowed
Generated on 02-11-2026, 3:35 AM. Verify before investing.
Gives more importance to longer time periods (10Y, 20Y) than shorter ones (1Y, 3Y). This balances out recent outperformance and gives a more realistic picture of what long-term returns might look like.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.98 L | 23.1% | -46.8% | 258.7% |
| 3 Years | ₹36.00 L | ₹48.36 L | 19.3% | -18.6% | 42.1% |
| 5 Years | ₹60.00 L | ₹94.97 L | 18.4% | -6.4% | 36.8% |
| 7 Years | ₹84.00 L | ₹1.63 Cr | 18.9% | 3.1% | 29.5% |
| 10 Years | ₹1.20 Cr | ₹3.18 Cr | 19.4% | 14.5% | 24.2% |
| 12 Years | ₹1.44 Cr | ₹4.63 Cr | 18.3% | 15.0% | 21.7% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY 50 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 23.1% | 14.3% | 11.0% | +8.8% |
| 3 Years | 19.3% | 11.0% | 17.8% | +8.3% |
| 5 Years | 18.4% | 10.4% | 18.0% | +8.0% |
| 7 Years | 18.9% | 10.6% | 17.0% | +8.3% |
| 10 Years | 19.4% | 11.4% | 16.8% | +8.0% |
| 12 Years | 18.3% | 11.3% | 16.4% | +7.0% |
| Duration | Mean | Median | Min | Max | Sharpe | Sortino | % Positive | Cat. Mean | Cat. Median |
|---|---|---|---|---|---|---|---|---|---|
| 1 Year | 21.9% | 16.6% | -34.1% | 155.8% | 0.64 | 2.65 | 82% | — | — |
| 3 Years | 20.1% | 20.7% | -6.9% | 38.6% | 1.44 | 9.05 | 98% | — | — |
| 5 Years | 18.8% | 17.6% | -3.3% | 33.6% | 1.99 | 40.87 | 100% | — | — |
| 10 Years | 19.3% | 18.5% | 11.4% | 24.4% | 4.86 | — | 100% | — | — |
Calmar Ratio by Duration
Compared against NIFTY 50
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +14.41 | 0.95 | 99.5% | 80.4% | 6.2% | -9.0% |
| 3 Years | +8.12 | 1.01 | 103.2% | 92.7% | 15.1% | 7.0% |
| 5 Years | +9.05 | 1.02 | 104.3% | 93.0% | 14.6% | 5.5% |
| 7 Years | +9.86 | 0.86 | 93.8% | 83.3% | 19.5% | 10.1% |
| 10 Years | +5.29 | 0.86 | 90.4% | 83.7% | 15.4% | 10.7% |
| 12 Years | +8.28 | 0.85 | 90.0% | 77.0% | 16.9% | 9.0% |
| 15 Years | +7.05 | 0.83 | 87.8% | 75.8% | 16.0% | 9.5% |
| # | Stock | % of NAV |
|---|---|---|
| 1 | Aurobindo Pharma Limited | 9.76% |
| 2 | Lloyds Metals And Energy Limited | 9.74% |
| 3 | Samvardhana Motherson International Ltd | 8.02% |
| 4 | Adani Enterprises Limited | 6.74% |
| 5 | Adani Green Energy Limited | 6.17% |
| 6 | Adani Power Limited | 5.47% |
| 7 | Bharti Airtel Ltd. | 5.34% |
| 8 | Glenmark Pharmaceuticals Ltd. | 3.98% |
| 9 | Zydus Lifesciences Limited | 3.66% |
| 10 | Sona BLW Precision Forgings Limited | 3.29% |